MOXYDAR, tablet for oral suspension 30 tablets
Active ingredients: Aluminum hydroxide, Aluminium phosphate, GOMME GUAR, Magnesium hydroxide
Commercialized according to BDPM
Tablet for oral suspension30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOXYDAR, comprimé pour suspension buvable
- Pharmaceutical form
- comprimé pour suspension buvable
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 30 comprimé(s)
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1991
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68966337CIP73311143CIP133400933111434Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALUMINIUM (OXYDE D') HYDRATÉcomprimé | 500 mg · un comprimé | SA |
| GOMME GUARcomprimé | 198,2 mg · un comprimé | SA |
| MAGNÉSIUM (HYDROXYDE DE)comprimé | 500 mg · un comprimé | SA |
| ALUMINIUM (PHOSPHATE D')comprimé | 300 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.